Authors: Ross, L Scarsella, A Raffanti, S Henry, K Becker, S Fisher, R Liao, QM Hirani, A Graham, N St Clair, M Hernandez, J

Citation: L. Ross et al., Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolatedfrom zidovudine-naive patients experiencing viremia on stavudine-containing regimens, AIDS RES H, 17(12), 2001, pp. 1107-1115

Authors: Haas, DW Clough, LA Johnson, BW Harris, VL Spearman, P Wilkinson, GR Fletcher, CV Fiscus, S Raffanti, S Donlon, R McKinsey, J Nicotera, J Schmidt, D Shoup, RE Kates, RE Lloyd, RM Larder, B

Citation: Dw. Haas et al., Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma, AIDS RES H, 16(15), 2000, pp. 1491-1502

Authors: Haas, DW Stone, J Clough, LA Johnson, B Spearman, P Harris, VL Nicotera, J Johnson, RH Raffanti, S Zhong, L Bergqwist, P Chamberlin, S Hoagland, V Ju, WD

Citation: Dw. Haas et al., Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection, CLIN PHARM, 68(4), 2000, pp. 367-374

Authors: Clough, LA D'Agata, E Raffanti, S Haas, DW

Citation: La. Clough et al., Factors that predict incomplete virological response to protease inhibitor-based antiretroviral therapy, CLIN INF D, 29(1), 1999, pp. 75-81